Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sarcosine in Obsessive Compulsive Disorder
NCT01031927Phase 2Completed
- Sponsor
- China Medical University Hospital
- Start
- Jun 2007
- Primary completion
- Feb 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of sarcosine in obsessive compulsive disorder (OCD), sponsored by China Medical University Hospital. Primary endpoint: Yale-Brown Obsessive Compulsive Scale at 10 weeks. Started Jun 2007; status: completed.
02
Drugs
sarcosine
03
Conditions
obsessive compulsive disorder (OCD)
Beyond the preview
Go deeper on NCT01031927.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01031927.